Cargando…
Difelikefalin in the Treatment of Chronic Kidney Disease-Associated Pruritus: A Systematic Review
Chronic kidney disease-associated pruritus (CKD-aP) is a chronic condition that significantly reduces the quality of life of patients with end-stage renal disease. The etiology is not fully understood, but imbalance in the activity of the opioid pathways, including downregulation of the kappa-opioid...
Autores principales: | Wala, Kamila, Szepietowski, Jacek C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414620/ https://www.ncbi.nlm.nih.gov/pubmed/36015082 http://dx.doi.org/10.3390/ph15080934 |
Ejemplares similares
-
Randomized Controlled Trial of Difelikefalin for Chronic Pruritus in Hemodialysis Patients
por: Fishbane, Steven, et al.
Publicado: (2020) -
Chronic Kidney Disease-Associated Pruritus
por: Agarwal, Puneet, et al.
Publicado: (2021) -
Elevated Level of Serum Neurotrophin-4, but Not of Brain-Derived Neurotrophic Factor, in Patients with Chronic Kidney Disease-Associated Pruritus
por: Wala-Zielińska, Kamila, et al.
Publicado: (2022) -
Endogenous Opioid Imbalance as a Potential Factor Involved in the Pathogenesis of Chronic Kidney Disease-Associated Pruritus in Dialysis Patients
por: Wala-Zielińska, Kamila, et al.
Publicado: (2023) -
Chronic Intractable Pruritus in Chronic Kidney Disease Patients: Prevalence, Impact, and Management Challenges — A Narrative Review
por: Świerczyńska, Karolina, et al.
Publicado: (2021)